Routine Stress Test Surveillance After PCI Is Not Recommended
Routine functional stress testing after PCI does not improve clinical outcomes and should not be performed in asymptomatic patients, regardless of whether they underwent high-risk PCI, had multivessel disease, left main disease, or presented with acute coronary syndrome. 1
Evidence Against Routine Surveillance Testing
The 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline explicitly states that routine periodic anatomic or ischemic testing in asymptomatic, nonsedentary patients with chronic coronary disease is not recommended. 1 This recommendation is supported by the POST-PCI trial, which randomized 1,706 high-risk patients (21% with left main disease, 43.5% with bifurcation disease, 69.8% with multivessel disease) to either routine functional stress testing at 12 months or standard care alone. 2
Key Trial Findings
No mortality or morbidity benefit: At 2 years, the composite primary endpoint of death, myocardial infarction, or hospitalization for unstable angina occurred in 5.5% of the routine testing group versus 6.0% in standard care (hazard ratio 0.90,95% CI 0.61–1.35, P=0.62). 2
Consistent across all high-risk subgroups: The lack of benefit persisted in patients with multivessel disease (6.2% vs 5.7%, HR 1.09, P=0.78) and left main disease (6.2% vs 5.7%, HR 1.09, P=0.85). 3
No benefit in ACS patients: Even among the 30.8% of patients who presented with acute coronary syndrome, routine functional testing at 12 months showed no advantage (6.6% vs 8.5%, HR 0.76, P=0.39). 4
Increased downstream procedures without benefit: A 2025 meta-analysis of four RCTs (6,290 patients) confirmed that routine functional stress testing was associated with a 49% increase in target lesion revascularization (RR 1.49,95% CI 1.02–2.18, P=0.038) without reducing major adverse cardiovascular events (RR 1.11,95% CI 0.82–1.51, P=0.480). 5
When to Perform Stress Testing After PCI
Stress testing should be reserved exclusively for symptomatic patients:
Accelerating symptoms or decreasing functional capacity: Patients with chronic coronary disease who develop new or worsening angina despite optimized guideline-directed medical therapy should undergo functional testing. 1
Symptom-driven approach: In a VA cohort study of 3,705 patients who underwent elective PCI, 79.7% of those who received stress testing within 2 years had symptoms consistent with obstructive coronary artery disease at the time of testing, demonstrating that symptom-oriented testing is the appropriate clinical practice. 6
No routine timing intervals: The POST-PCI trial showed no rapid increases in stress testing at 6 months or 1 year after PCI, indicating that arbitrary surveillance intervals are not clinically justified. 6
Critical Pitfalls to Avoid
Do not order "routine 1-year post-PCI stress tests": This practice increases invasive angiography and repeat revascularization rates without improving death, MI, or hospitalization outcomes. 2, 5
Do not assume high-risk anatomy requires surveillance: Even patients with diabetes (38.7% in POST-PCI), diffuse long lesions (70.1%), or drug-eluting stents (96.4%) derived no benefit from routine testing. 2
Avoid routine angiographic follow-up: The ReACT trial demonstrated that routine follow-up coronary angiography 8–12 months after PCI increased early revascularization without clinical benefit during 4.6 years of follow-up. 1
What to Do Instead: Optimize Medical Therapy and Symptom Monitoring
Focus on guideline-directed medical therapy: The ISCHEMIA trial showed that only patients presenting with daily, weekly, or monthly angina experienced prompt and durable symptom improvement with invasive management compared to conservative care. 1
Educate patients on anginal symptoms: Establish a baseline 12-lead ECG that can be compared to future tracings if symptoms develop. 1
Reserve testing for clinical change: Functional testing should be performed only when there is a change in symptoms or functional status that would alter management. 1